Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Neoplasm”

4,189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,189 results

Early research (Phase 1)Study completedNCT00739453
What this trial is testing

Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Early research (Phase 1)Study completedNCT02897375
What this trial is testing

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Who this might be right for
Solid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more
Emory University 71
Testing effectiveness (Phase 2)UnknownNCT01100801
What this trial is testing

Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients

Who this might be right for
Recurrent Gastric Cancer
National University Hospital, Singapore 90
Early research (Phase 1)WithdrawnNCT02432612
What this trial is testing

Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
GW Pharmaceuticals Ltd
Early research (Phase 1)UnknownNCT03662815
What this trial is testing

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor

Who this might be right for
Advanced Malignant Solid Tumor
Sir Run Run Shaw Hospital 30
Not applicableUnknownNCT03619668
What this trial is testing

Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment

Who this might be right for
Rectal CancerRectal AdenocarcinomaLocally Advanced Malignant Neoplasm
Aalborg University Hospital 16
Very early researchNot Yet RecruitingNCT06825455
What this trial is testing

Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancersPeritoneal (metastatic) Cancer
Peking University 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04632108
What this trial is testing

A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Malignant Solid Tumor
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 199
Testing effectiveness (Phase 2)Study completedNCT00140348
What this trial is testing

Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Who this might be right for
Prostate Cancer
Cell Genesys 80
Large-scale testing (Phase 3)Looking for participantsNCT04749108
What this trial is testing

Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma

Who this might be right for
Locally Advanced Malignant NeoplasmRectal Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 1,075
Large-scale testing (Phase 3)Study completedNCT01661790
What this trial is testing

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Who this might be right for
Malignant Pleural Effusion
Chinese PLA General Hospital 72
Early research (Phase 1)Study completedNCT00478725
What this trial is testing

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 10
Early research (Phase 1)Study completedNCT00551850
What this trial is testing

A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients

Who this might be right for
Advanced CancerRefractory Cancer
AVEO Pharmaceuticals, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT01314118
What this trial is testing

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Who this might be right for
Prostate CancerProstatic Neoplasm
Janssen Biotech, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT03562897
What this trial is testing

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Who this might be right for
CarcinomaOvarian NeoplasmEndocrine Gland Neoplasm+10 more
Catalysis SL 40
Early research (Phase 1)Ended earlyNCT06457997
What this trial is testing

PHN-010 in Patients With Advanced Solid Tumors

Who this might be right for
Lung CancerColon CancerEndometrial Cancer+4 more
Pheon Therapeutics 26
Testing effectiveness (Phase 2)WithdrawnNCT03818997
What this trial is testing

Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer

Who this might be right for
Esophageal CancerBiliary Tract CancerGastroEsophageal Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Study completedNCT03084640
What this trial is testing

Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Regeneron Pharmaceuticals 30
Early research (Phase 1)Ended earlyNCT06302140
What this trial is testing

A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers

Who this might be right for
Advanced Cancer
Viracta Therapeutics, Inc. 8
Testing effectiveness (Phase 2)Looking for participantsNCT05101356
What this trial is testing

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

Who this might be right for
Advanced AdenocarcinomaAdvanced Malignant Solid NeoplasmMetastatic Adenocarcinoma+3 more
Tianhong Li 77
Load More Results